These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 19730248
1. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L, FITENAT Study Group. Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248 [Abstract] [Full Text] [Related]
2. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran. Bagheri M, Rad IA, Nanbakhsh F. Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779 [Abstract] [Full Text] [Related]
4. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960 [Abstract] [Full Text] [Related]
5. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis. Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL. Haemostasis; 2001 Dec; 31(2):99-105. PubMed ID: 11684865 [Abstract] [Full Text] [Related]
6. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, Batun S, Isi H. Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893 [Abstract] [Full Text] [Related]
8. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I. Arthritis Rheum; 2004 Apr 15; 51(2):177-83. PubMed ID: 15077257 [Abstract] [Full Text] [Related]
14. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, Melissinos C, Philalithis P, Iliadis K, Kontaxis A, Liberatos K, Pangratis N, Nasioulas G. Int Angiol; 2003 Mar 15; 22(1):79-82. PubMed ID: 12771861 [Abstract] [Full Text] [Related]
18. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ozmen F, Ozmen MM, Ozalp N, Akar N. Ulus Travma Acil Cerrahi Derg; 2009 Mar 15; 15(2):113-9. PubMed ID: 19353312 [Abstract] [Full Text] [Related]